A veterinary practice buy-in has no published average price — no industry survey tracks one, and AVMA publishes no valuation guidance at all.
What is known is mechanical: the price is typically derived from the practice's normalized earnings times a multiple, the money buys actual ownership units rather than a bigger paycheck, and the terms that shape the deal are the ones no source publishes.
Here is how it fits together.
What a buy-in actually buys — and what it doesn't
A practice buy-in is a purchase.
You pay for actual ownership units in the practice's legal entity, and from that point you hold a share of its profits, its losses, and its governance.
It is not a promotion with a new title, and it is not the same thing as a bonus tied to the practice's performance.
Three arrangements get described loosely as "buying in," and they are not interchangeable.
An equity purchase transfers actual ownership units or shares in the practice entity to you — title changes hands.
A profit share pays you a portion of practice profits without transferring any ownership: no title, no governance, and no share of the enterprise's value if it is later sold. "Sweat equity" is the colloquial term for building a stake through below-market compensation or deferred pay in lieu of a cash purchase.
No industry body publishes formal definitions of these terms — AVMA, the specialty associations and the valuation firms were all checked — so treat the definitions written into any agreement in front of you as the ones that count.
The distinction matters because the advancement path most associates know — medical director, regional roles — is a career ladder inside employment, not ownership.
Where a genuine route to equity exists, it is overwhelmingly at independently owned practices.
How the two employment models compare on everything else is covered in our corporate vs. private practice page.
How the price gets set
Start with the honest part: no named survey publishes an average price for buying into a veterinary practice.
AVMA's Veterinary Economics hub lists a market-share estimator, a P&L calculator, a salary estimator and its annual Economic State of the Profession report — but no practice-valuation, acquisition or buy-in guidance at all.
Anyone quoting you "the typical buy-in" is extrapolating.
What the market does instead is described consistently in valuation commentary: value the practice's earnings.
The income approach takes the practice's normalized earnings — EBITDA, adjusted for one-off items — and multiplies them by a market multiple, and it is what one M&A advisory firm describes as what virtually every institutional buyer uses to underwrite a veterinary acquisition (Transitions Elite, August 2026).
The asset approach — adding up equipment, inventory and property — is the alternative, and the same source notes it typically produces a value far below what a buyer would actually pay, because in a service business the value sits in cash flow rather than on the balance sheet.
The published multiples, attributed to the two firms that publish them, run as follows.
Transitions Elite (August 2026) cites roughly 4x–7x EBITDA for single-doctor practices under $1M in revenue, 6x–9x for multi-doctor practices at $1–2M, and low-teens multiples for strong multi-doctor practices above $2M.
Sofer Advisors (updated April 2026, 2024 reference year) cites 5x–7x for small two-to-three-doctor groups, 7x–9x for four-to-six-doctor practices, and 8x–12x+ for emergency and specialty hospitals over $5M in revenue. These are two competing advisory firms, not a survey — treat every number as directional market commentary, and a specific practice's price as a derivation from that practice's own financials rather than anything a multiple range can tell you.
Where these numbers come from
What the money buys: the income data
The case for buying in is the gap between owner and associate income, and this is where the sourced data is strong.
AVMA's 2025 Report on the Economic State of the Veterinary Profession — income earned in 2023, reported in 2024 — puts companion-animal-exclusive practice owners at a mean of $191,352 and a median of $160,000 (n=275), against associates in the same practice type at a mean of $146,196 and a median of $133,000 (n=873).
That pattern is not a companion-animal quirk: owner income exceeds associate income at every practice type AVMA tracks in this table, and ownership is the biggest single income lever in the profession's own data — larger than any documented corporate-versus-private difference.
Keep it in proportion, though.
In the same Census, 57.4% of private-practice veterinarians are associates and 23.8% are practice owners — most veterinarians never buy in.
The figures above are means and medians across owners whose practices, debts and arrangements differ enormously; what you would personally earn from a stake depends on the practice's own P&L, which is exactly what the valuation section above is about.
Worth knowing before you buy, too: as an associate your pay is most likely structured as ProSal — a recoverable draw against a production percentage, which AVMA data put at roughly 56% of associates in 2024.
What happens to that arrangement when you become a co-owner is a negotiation, not a given.
The mechanics are on our ProSal and production pay page.
How a buy-in is structured — and the terms nobody publishes
Mechanically, a buy-in transfers ownership units in the practice's legal entity from the selling owner to you, in exchange for cash, financing, or a combination.
In states that restrict who may own a practice, the buyer has to be a licensed veterinarian — around 18 states reserve ownership to licensed vets according to two published analyses, under the corporate-practice-of-veterinary-medicine doctrine.
Who can own, and the PC/MSO structure corporate groups use around those rules, is covered in full on our practice ownership page.
Beyond that first sentence, the structural terms — how the price is paid over time, whether the stake vests year by year, what percentage per year, how the purchase is financed — are where the sourcing runs out. No source that meets a named-survey bar publishes a typical associate buy-in vesting schedule, percentage, or financing structure. If someone quotes you a "standard" one, they are guessing, and the agreement in front of you is the only structure that is real.
What that means practically: the questions in the final section below are not a formality.
They are the deal, and every one of them is negotiable before signature and effectively fixed after.
The restrictive covenants ride along
A buy-in agreement sits alongside your employment contract, not instead of it — and the restrictive covenants are usually the part that changes character when you become an owner.
AVMA's own stated norms for a non-compete are a radius covering roughly 80% of the practice's patient base, and a standard duration of one to three years.
Whether any non-compete holds up at all is decided entirely by your state — California, Minnesota, North Dakota and Oklahoma void them essentially outright.
Check specifically whether your restriction terms change at closing: what the radius is measured from, how long it runs, and whether it differs now that you are a part-owner rather than an employee.
A partner leaving a practice is a different fact pattern from an associate resigning, and the agreement should say which set of rules applies to you.
State-by-state enforceability, including the four void states and the access-to-care argument, is on our non-compete page.
AVMA's contract guidance closes with a line worth repeating verbatim: "You should always have a lawyer review any contract before you sign it." For a buy-in specifically, that means someone who reads entity and tax documents, not just employment terms.
General information, not legal advice
Before you sign: the questions with no published answers
Every structural term below should have a written answer in the agreement itself.
None of them has an industry-standard default you can fall back on — which is precisely why each one needs asking.
- Exactly what am I buying — units or shares in which legal entity, and what percentage of it?
- What valuation produced the price, who prepared it, and which earnings figure does the multiple apply to?
- How is the price paid — lump sum, installments, or financed — and what happens to the balance if I leave the practice?
- Does the stake vest over time, and what do I actually own if I depart mid-schedule?
- What happens to my current compensation — base, ProSal, negative accrual — once I'm an owner?
- How are profits distributed versus retained in the practice, and who decides?
- What do I owe if the practice loses money — and is my liability capped at my investment?
- What happens if another owner dies, becomes disabled, exits, or wants to sell?
- Do my non-compete and non-solicitation terms change at closing — and what is the radius measured from?
- Has a veterinary-practice attorney in my state reviewed the full agreement?
None of these questions has a published "normal" answer, and that is the honest state of this market: the multiples are commentary, the income data is real, and the structural terms live in the document itself.
Reading the employment contract that usually sits underneath a buy-in?
Our associate contract checklist covers it clause by clause.
And if you are weighing ownership against employment offers while you decide, browse open veterinarian positions to see what the market is actually offering.